Nathoo Narendra, Chetry Runjan, van Dellen James R, Connolly Catherine, Naidoo Richard
Department of Neurosurgery, Wentworth Hospital, Nelson R. Mandela School of Medicine, University of Natal, South Africa.
J Neurosurg. 2003 Feb;98(2):302-6. doi: 10.3171/jns.2003.98.2.0302.
The presence of the apolipoprotein E-epsilon4 (APOE-epsilon4) allele is reported to be associated with poor outcome after traumatic brain injury (TBI). This study was performed to determine if the presence of the APOE-epsilon4 allele influenced outcome in a cohort of black patients with TBI who had homogeneous neuropathological findings.
Venous blood was collected at the time of admission to determine the APOE genotype in black Zulu-speaking patients who presented with traumatic cerebral contusions. The frequency of the APOE-epsilon4 allele's appearance was correlated with outcome at a minimum of 6 months of follow up. Univariate and multivariate analyses were performed to determine independent risk factors and to control for confounding factors. In 110 black Zulu-speaking patients with traumatic cerebral contusions, genotypes for APOE were analyzed. Eleven of 45 (24.4%) with the APOE-epsilon4 allele experienced a poor outcome, compared with 10 (15.4%) of 65 without this allele (p = 0.34). Both patients with homozygous APOE-epsilon4 alleles experienced a good outcome (Glasgow Outcome Score 5). Univariate and multivariate analysis revealed no significant relationship in patients with the APOE-epsilon4 allele with regard to age, admission Glasgow Comas Scale score, contusion volume, type of neurosurgical management, and outcome. The risk of a poor outcome was, however, greater in patients with the APOE-epsilon4 allele (relative risk 1.59; 95% confidence interval 0.74-3.42).
The authors recorded no relationship between APOE-epsilon4 allele status and outcome after TBI in black patients. Given the high regional susceptibility to the APOE gene, further studies, possibly even community-based investigations and studies conducted in other geographic areas, are probably warranted.
据报道,载脂蛋白E-ε4(APOE-ε4)等位基因的存在与创伤性脑损伤(TBI)后的不良预后相关。本研究旨在确定APOE-ε4等位基因的存在是否会影响一组具有同质神经病理学发现的黑人TBI患者的预后。
在入院时采集静脉血,以确定患有创伤性脑挫伤的讲祖鲁语的黑人患者的APOE基因型。APOE-ε4等位基因出现的频率与至少6个月随访后的预后相关。进行单因素和多因素分析以确定独立危险因素并控制混杂因素。对110名患有创伤性脑挫伤的讲祖鲁语的黑人患者的APOE基因型进行了分析。45名携带APOE-ε4等位基因的患者中有11名(24.4%)预后不良,而65名不携带该等位基因的患者中有10名(15.4%)预后不良(p = 0.34)。两名携带纯合APOE-ε4等位基因的患者预后良好(格拉斯哥预后评分5分)。单因素和多因素分析显示,携带APOE-ε4等位基因的患者在年龄、入院时格拉斯哥昏迷量表评分、挫伤体积、神经外科治疗类型和预后方面无显著相关性。然而,携带APOE-ε4等位基因的患者预后不良的风险更高(相对风险1.59;95%置信区间0.74 - 3.42)。
作者记录了黑人患者中APOE-ε4等位基因状态与TBI后预后之间无相关性。鉴于该地区对APOE基因的高易感性,可能需要进一步研究,甚至可能是基于社区的调查以及在其他地理区域进行的研究。